HEALTH
By Scott Dance, The Baltimore Sun | May 8, 2013
State health officials don't know how often Marylanders use medications mixed in facilities lacking safety oversight, like a Massachusetts facility linked to three deaths here, but a newly passed law could tell them — and help demonstrate a gap in federal regulation. Batches of sterile drugs from so-called compounding pharmacies will be subject to state review under the measure Gov. Martin O'Malley signed this month. And pharmacists and doctors who perform compounding, in which drugs are somehow altered from their Food and Drug Administration-approved form, will face an extra layer of permits and inspections for drugs used in Maryland.
HEALTH
By Scott Dance, The Baltimore Sun | April 11, 2013
A global nonprofit that battles the spread of viruses has moved into the University of Maryland BioPark after sprouting from the university's Institute of Human Virology. Global Virus Network is the west side research park's newest tenant. It moved from incubator space in the virology institute, within the University of Maryland School of Medicine. GVN combines the resources and expertise of 30 virology research centers in 21 countries, helping them to share information and ideas to explore vaccine development, understand virus behavior and respond to viral outbreaks.
HEALTH
By Scott Dance, The Baltimore Sun | January 6, 2013
A national outbreak of fungal meningitis linked to a tainted steroid killed two Marylanders. Nearly two dozen people living with the disease and hundreds of others who may have been exposed fear they may be next. Sheila Smelkinson began suffering in July from pain in her lower back and right leg that kept the Pikesville resident awake for all but a few hours each night. Cortisone shots, one in August and a second in September, relieved her discomfort - until she received a call informing her the medication was among batches contaminated with fungus in a Massachusetts pharmaceutical facility.
HEALTH
By Andrea K. Walker, The Baltimore Sun | December 21, 2012
The pharmacy at the center of a fungal meningitis outbreak that has hit 19 states said Friday it has declared Chapter 11 bankruptcy in Massachusetts. The New England Compounding Center also said it plans to establish a fund to compensate those affected by the outbreak. The outbreak has sickened 620 people and killed 39. In Maryland, 25 people have gotten ill and two have died. The outbreak is linked to three lots of a steroid injection used to treat back pain that clinics and medical facilities bought from New England Compounding Center.
HEALTH
By Scott Dance and Andrea K. Walker, The Baltimore Sun | December 12, 2012
John C. "Jack" Millhausen, an 84-year-old Fallston resident, is at least the second Marylander to die of fungal meningitis in a national epidemic that experts say is slowing but about which many questions remain. Millhausen died Nov. 15 at Gilchrist Hospice Care in Towson, his family said, not long after receiving a spinal shot of a contaminated steroid, several batches of which have caused nearly 600 cases of infections and 37 deaths across the country. Maryland health officials confirmed a second death in the state from the outbreak on Monday but would not confirm that it was Millhausen's, citing confidentiality rules.
HEALTH
By Kevin Rector, The Baltimore Sun | December 10, 2012
A second person has died in Maryland in connection with a fungal meningitis outbreak tied to tainted steroid injections that has resulted in hundreds of infections across the country, according to new statistics released Monday. In all, 25 cases have been identified in the state, according to the Centers for Disease Control and Prevention. Details of the death were not immediately available. The first Maryland death was reported in October. Nationally, a total of 590 cases have been identified and 37 people have died in the outbreak, which involves patients who received steroid injections tied to the distributor New England Compounding Center in Framingham, Mass.